Uds statin therapy measure
WebMeasure total cholesterol, high-density lipoprotein cholesterol (HDL-C), and non-HDL cholesterol (total cholesterol minus HDL-C) levels in all people after 3 months of statin treatment. If a greater than 40% reduction in non-HDL-C is not achieved: Discuss adherence and timing of dose. Optimize adherence to diet and lifestyle measures. http://bphcdata.net/docs/uds_clinical_quality_measures.pdf
Uds statin therapy measure
Did you know?
Web18 Jul 2014 · 1.4.12 The decision whether to start statin therapy should be made after an informed discussion between the clinician and the person about the risks and benefits of statin treatment, ... before starting a statin. Measure liver transaminase within 3 months of starting treatment and at 12 months, but not again unless clinically indicated. ... WebSection I - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease Section J - Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet Section …
Web13 Aug 2024 · Addressing measures related to clinical guidelines may require taking a different path of success than other measures, such as adherence measures like the “proportion of days covered” (PDC). Because both measures require a patient to be prescribed and then receive a statin therapy, a pharmacist and the patient are not typically … http://bphcdata.net/docs/uds_clinical_quality_measures.pdf
Web31 Mar 2016 · View Full Report Card. Fawn Creek Township is located in Kansas with a population of 1,618. Fawn Creek Township is in Montgomery County. Living in Fawn Creek … WebStatin Therapy for Patients With Cardiovascular Disease : SPC . The percentage of males 21–75 years of age and females 40–75 years of age during the measurement year, who were identified as having clinical atherosclerotic cardiovascular disease (ASCVD) and met the following criteria. The following rates are reported: 1. Received Statin Therapy.
WebUDS Reporting Considerations BPHC requirements and guidance to be applied to the specific measure and may differ from or expand on the eCQM specifications. The clinical …
http://bphcdata.net/docs/table_6b.pdf golden state water californiaWebMeasure total cholesterol, HDL-C and non-HDL-C in all people on high-intensity statin at 3 months of treatment and once stable annually. LFTs: Measure ALT within 3 months of starting treatment and at 12 months, but not again unless clinically indicated. Do not routinely exclude from statin therapy people who have an ALT that is raised but less hd redefinition\\u0027sWeb15 Apr 2024 · Strong evidence supports moderate-dose statins as the best therapy in primary prevention for patients at elevated risk, with relative risk reductions in cardiovascular events and mortality of 20% ... hd recovery imageWebThe UDS Clinical Measures Exclusions and Exceptions’ resource was developed to support accurate clinical measure reporting on Tables 6B and 7 for the 2024 UDS report. It is … hd redefinition\u0027sWebMeasures Collected Using Electronic Clinical Data Systems: Depression Remission or Response for Adolescents and Adults (DRR) Diabetes: Hemoglobin A1c (HbA1c) Poor … golden state water company apple valley caWebFor audit purposes a serum cholesterol of <5mmol/l has been used nationally in the UK and is a useful measure of organisational performance at practice or CCG level. ... safety labels for statins recommend that liver enzyme tests should be performed before starting statin therapy and only as clinically indicated thereafter. NICE recommends an ... hd red 6000 trWebFactors such as polypharmacy, frailty, and comorbidities should be taken into account before starting statin therapy. A Strength of recommendation: High NICE (2016) recommends low-dose atorvastatin for patients who have a 10% or greater 10-year risk of developing CVD (using the QRISK2 calculator), and for patients with chronic kidney disease. hdr edge browser